These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31850536)

  • 41. [Challenges in the treatment of patients with type 2 diabetes mellitus and obesity].
    Manzanares Errazu JM
    Nutr Hosp; 2002 Feb; 17 Suppl 1():1-6. PubMed ID: 11928531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of an obese diabetic].
    Svacina S
    Vnitr Lek; 2010 Oct; 56(10):1078-81. PubMed ID: 21105456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bariatric Surgery in Type 1 Diabetes Mellitus: A Systematic Review.
    Mahawar KK; De Alwis N; Carr WR; Jennings N; Schroeder N; Small PK
    Obes Surg; 2016 Jan; 26(1):196-204. PubMed ID: 26452482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current pharmacotherapy for obesity.
    Srivastava G; Apovian CM
    Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Complications of Bariatric Surgery Patients with Type 2 Diabetes in the World: A Systematic Review and Meta-Analysis.
    Kabir A; Mousavi S; Pazouki A
    Curr Diabetes Rev; 2019; 15(1):49-61. PubMed ID: 29623848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.
    Janero DR
    Expert Opin Drug Discov; 2014 Mar; 9(3):221-8. PubMed ID: 24397872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review.
    Maggard-Gibbons M; Maglione M; Livhits M; Ewing B; Maher AR; Hu J; Li Z; Shekelle PG
    JAMA; 2013 Jun; 309(21):2250-61. PubMed ID: 23736734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Weight Management Strategies for the Patient with Diabetes.
    Jakicic JM; Jackson RE
    Curr Cardiol Rep; 2021 Jul; 23(8):104. PubMed ID: 34196800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic surgery for the treatment of type 2 diabetes in obese individuals.
    Cummings DE; Rubino F
    Diabetologia; 2018 Feb; 61(2):257-264. PubMed ID: 29224190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical considerations for the management of residual diabetes following bariatric surgery.
    Kashyap SR; Schauer P
    Diabetes Obes Metab; 2012 Sep; 14(9):773-79. PubMed ID: 22288474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microvascular complications of obesity and diabetes-Role of bariatric surgery.
    Bashir B; Iqbal Z; Adam S; Ferdousi M; Chick W; Hussein HA; Syed AA; Le Roux CW; Cohen RV; Malik RA; Soran H
    Obes Rev; 2023 Oct; 24(10):e13602. PubMed ID: 37515402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults.
    Bensignor MO; Kelly AS; Arslanian S
    Front Endocrinol (Lausanne); 2022; 13():1043650. PubMed ID: 36387846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.
    Cornell S; D'Souza J
    Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapy for obesity in menopausal women.
    Samat A; Rahim A; Barnett A
    Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers to metabolic surgery and how to address them.
    Laville M; Robert M; Segrestin B
    Metabolism; 2024 Mar; 152():155764. PubMed ID: 38135182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum.
    Cefalu WT; Bray GA; Home PD; Garvey WT; Klein S; Pi-Sunyer FX; Hu FB; Raz I; Van Gaal L; Wolfe BM; Ryan DH
    Diabetes Care; 2015 Aug; 38(8):1567-82. PubMed ID: 26421334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery.
    Fabbrini E; Klein S
    Clin Cornerstone; 2008; 9(1):41-8; discussion 49-51. PubMed ID: 19046739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.